Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children
Clinical trial NCT07137884 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07137884
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-10-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.